18 Apr 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide’s presentation at Økonomisk Ugebrev’s Life Science event is now available


November 26, 2020

Copenhagen, Denmark, 26 November 2020 – Yesterday, FluoGuide A/S (“FluoGuide” or the “Company”) presented at Økonomisk Ugebrev’s Life Science event. The recorded presentation is now available (in Danish only) here (

Økonomisk Ugebrev Life Science conveys the potential of Nordic equities in the BioTech and pharmaceutical sectors. The magazine is aimed at both the prudent investor with an interest in stable pharmaceutical and MedTech companies, as well as investors who are prepared to go after the very large returns in the BioTech sector (

The event was moderated by Økonomisk Ugebrev Life Science’s analysts, Steen Albrechtsen, Morten Larsen and Lars Hatholt.